1. Home
  2. MXE vs PYPD Comparison

MXE vs PYPD Comparison

Compare MXE & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mexico Equity and Income Fund Inc. (The)

MXE

Mexico Equity and Income Fund Inc. (The)

N/A

Current Price

$12.30

Market Cap

53.2M

Sector

Finance

ML Signal

N/A

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

N/A

Current Price

$3.90

Market Cap

66.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MXE
PYPD
Founded
1990
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Finance Companies
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.2M
66.2M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
MXE
PYPD
Price
$12.30
$3.90
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$12.00
AVG Volume (30 Days)
5.8K
90.4K
Earning Date
01-01-0001
02-11-2026
Dividend Yield
2.66%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.40
$2.30
52 Week High
$11.51
$4.10

Technical Indicators

Market Signals
Indicator
MXE
PYPD
Relative Strength Index (RSI) 64.89 59.46
Support Level $11.91 $3.90
Resistance Level $12.50 $4.10
Average True Range (ATR) 0.22 0.10
MACD 0.00 -0.01
Stochastic Oscillator 77.60 56.52

Price Performance

Historical Comparison
MXE
PYPD

About MXE Mexico Equity and Income Fund Inc. (The)

Mexico Equity and Income Fund Inc. is a closed-end, non-diversified management investment company that aims for long-term capital appreciation and current income. It prominently invests in equity, convertible securities, and debt issued by Mexican companies, operating across various sectors. The fund benchmarks its performance against the Mexbol and MSCI Mexico Index. The company provides a vehicle to investors who wish to invest in Mexican companies through a managed non-diversified portfolio as part of their overall investment program.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: